Why is Vaxart, Inc. ?
- OPERATING CASH FLOW(Y) Highest at USD 33.99 MM
- NET PROFIT(HY) At USD -8.31 MM has Grown at 72.81%
- ROCE(HY) Highest at 66.97%
- Over the past year, while the stock has generated a return of 97.88%, its profits have risen by 124.4% ; the PEG ratio of the company is 0.1
- Institutional investors have decreased their stake by -7.03% over the previous quarter and collectively hold 13.83% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
- The stock has generated a return of 97.88% in the last 1 year, much higher than market (S&P 500) returns of 15.76%
How much should you hold?
- Overall Portfolio exposure to Vaxart, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Vaxart, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 33.99 MM
At USD -8.31 MM has Grown at 72.81%
Highest at 66.97%
Fallen by -3% (YoY
Higher at USD 170.65 MM
Lowest at -62.45 %
At USD -13.46 MM has Fallen at -243.6%
At USD -13.49 MM has Fallen at -245.5%
Lowest at USD 27.18 MM
Lowest at USD -12.43 MM
Lowest at -45.73 %
Here's what is working for Vaxart, Inc.
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Vaxart, Inc.
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales






